CKD Bio Corp. (063160) Ratios

― Followers

CKD Bio Corp. Ratios

KR:063160's free cash flow for Q2 2026 was ₩0.02. For the 2026 fiscal year, KR:063160's free cash flow was decreased by ₩ and operating cash flow was ₩-0.12. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	1.06	0.90	1.27	1.13	1.51
Quick Ratio	0.33	0.26	0.38	0.43	0.55
Cash Ratio	<0.01	<0.01	0.01	0.04	0.06
Solvency Ratio	0.03	0.07	0.17	-0.04	<0.01
Operating Cash Flow Ratio	<0.01	-0.03	0.15	-0.07	-0.04
Short-Term Operating Cash Flow Coverage	<0.01	-0.03	0.20	-0.10	-0.06
Net Current Asset Value	₩ -41.00B	₩ -36.59B	₩ -38.27B	₩ -58.99B	₩ -41.33B
Leverage Ratios
Debt-to-Assets Ratio	0.50	0.48	0.46	0.50	0.44
Debt-to-Equity Ratio	1.24	1.14	1.00	1.19	0.94
Debt-to-Capital Ratio	0.55	0.53	0.50	0.54	0.48
Long-Term Debt-to-Capital Ratio	0.27	0.12	0.31	0.36	0.35
Financial Leverage Ratio	2.45	2.36	2.17	2.39	2.11
Debt Service Coverage Ratio	0.08	0.15	0.41	-0.02	0.07
Interest Coverage Ratio	-1.43	0.64	2.08	-4.04	-5.03
Debt to Market Cap	2.12	1.28	1.08	1.09	1.04
Interest Debt Per Share	27.99K	27.43K	24.88K	27.69K	25.86K
Net Debt to EBITDA	17.26	7.45	4.17	-87.89	58.72
Profitability Margins
Gross Profit Margin	8.61%	16.31%	20.93%	3.12%	10.76%
EBIT Margin	-4.65%	2.25%	8.43%	-11.98%	-10.03%
EBITDA Margin	5.40%	12.03%	18.15%	-1.02%	1.47%
Operating Profit Margin	-5.10%	2.25%	6.38%	-12.57%	-9.47%
Pretax Profit Margin	-6.91%	-1.85%	5.37%	-15.09%	-11.91%
Net Profit Margin	-6.79%	-1.80%	5.07%	-15.09%	-10.70%
Continuous Operations Profit Margin	-6.79%	-1.80%	5.07%	-15.09%	-10.70%
Net Income Per EBT	98.27%	97.36%	94.41%	99.98%	89.85%
EBT Per EBIT	135.50%	-82.29%	84.14%	120.07%	125.86%
Return on Assets (ROA)	-3.67%	-0.96%	3.06%	-8.23%	-5.34%
Return on Equity (ROE)	-8.59%	-2.27%	6.64%	-19.66%	-11.30%
Return on Capital Employed (ROCE)	-4.80%	2.44%	5.65%	-10.33%	-6.39%
Return on Invested Capital (ROIC)	-2.93%	1.28%	3.91%	-7.42%	-4.61%
Return on Tangible Assets	-3.73%	-0.98%	3.13%	-8.41%	-5.41%
Earnings Yield	-15.49%	-2.59%	7.21%	-18.22%	-12.77%
Efficiency Ratios
Receivables Turnover	3.96	4.33	5.49	2.61K	5.68
Payables Turnover	23.59	21.94	22.73	23.24	16.92
Inventory Turnover	1.58	1.38	1.69	2.25	1.77
Fixed Asset Turnover	1.04	1.03	1.08	0.93	0.86
Asset Turnover	0.54	0.53	0.60	0.55	0.50
Working Capital Turnover Ratio	15.71	36.68	9.12	5.83	3.06
Cash Conversion Cycle	307.78	331.39	266.93	146.75	248.47
Days of Sales Outstanding	92.23	84.39	66.52	0.14	64.27
Days of Inventory Outstanding	231.02	263.64	216.47	162.32	205.78
Days of Payables Outstanding	15.47	16.64	16.06	15.71	21.58
Operating Cycle	323.25	348.03	282.98	162.46	270.05
Cash Flow Ratios
Operating Cash Flow Per Share	183.43	-754.78	2.56K	-1.32K	-584.14
Free Cash Flow Per Share	-1.78K	-1.99K	1.78K	-3.28K	-1.90K
CapEx Per Share	1.96K	1.24K	780.63	1.96K	1.32K
Free Cash Flow to Operating Cash Flow	-9.68	2.64	0.69	2.49	3.26
Dividend Paid and CapEx Coverage Ratio	0.09	-0.56	2.90	-0.67	-0.41
Capital Expenditure Coverage Ratio	0.09	-0.61	3.28	-0.67	-0.44
Operating Cash Flow Coverage Ratio	<0.01	-0.03	0.11	-0.05	-0.02
Operating Cash Flow to Sales Ratio	<0.01	-0.03	0.08	-0.05	-0.02
Free Cash Flow Yield	-14.05%	-9.80%	8.08%	-13.56%	-7.98%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-6.47	-38.68	13.87	-5.49	-7.83
Price-to-Sales (P/S) Ratio	0.44	0.70	0.70	0.83	0.84
Price-to-Book (P/B) Ratio	0.58	0.88	0.92	1.08	0.89
Price-to-Free Cash Flow (P/FCF) Ratio	-7.13	-10.20	12.38	-7.37	-12.54
Price-to-Operating Cash Flow Ratio	69.02	-26.96	8.60	-18.38	-40.83
Price-to-Earnings Growth (PEG) Ratio	0.06	0.29	-0.10	-0.12	-0.05
Price-to-Fair Value	0.58	0.88	0.92	1.08	0.89
Enterprise Value Multiple	25.40	13.25	8.05	-169.31	115.93
Enterprise Value	216.76B	255.23B	250.80B	276.06B	265.11B
EV to EBITDA	25.38	13.25	8.05	-169.31	115.93
EV to Sales	1.37	1.59	1.46	1.72	1.70
EV to Free Cash Flow	-22.25	-23.31	25.73	-15.33	-25.41
EV to Operating Cash Flow	215.41	-61.61	17.87	-38.21	-82.73
Tangible Book Value Per Share	20.88K	22.13K	22.70K	21.31K	26.24K
Shareholders’ Equity Per Share	21.80K	23.14K	23.88K	22.43K	26.94K
Tax and Other Ratios
Effective Tax Rate	0.02	0.03	0.06	<0.01	0.10
Revenue Per Share	28.82K	29.16K	31.31K	29.23K	28.44K
Net Income Per Share	-1.96K	-526.21	1.59K	-4.41K	-3.04K
Tax Burden	0.98	0.97	0.94	1.00	0.90
Interest Burden	1.49	-0.82	0.64	1.26	1.19
Research & Development to Revenue	-0.01	0.02	0.08	0.08	0.10
SG&A to Revenue	0.05	0.04	0.03	0.08	0.06
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	-0.09	1.43	1.61	0.30	0.19

Currency in KRW